12 Health Care Stocks Moving In Monday's Intraday Session
Portfolio Pulse from Benzinga Insights
Several healthcare stocks experienced significant price movements during Monday's intraday session. Miromatrix Medical, Eargo, Reviva Pharmaceuticals, Motus GI Hldgs, BioXcel Therapeutics, and VYNE Therapeutics saw their share prices increase, while LumiraDx, Qualigen Therapeutics, Tenax Therapeutics, Better Therapeutics, ABVC BioPharma, and Biotricity experienced declines.
October 30, 2023 | 5:30 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
BioXcel Therapeutics shares moved upwards by 25.88% to $3.81.
The significant increase in BioXcel Therapeutics' share price is likely to have a positive impact on the company's stock in the short term.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
Eargo stock moved upwards by 52.38% to $2.56.
The significant increase in Eargo's share price is likely to have a positive impact on the company's stock in the short term.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
Miromatrix Medical shares increased by 217.2% to $3.3.
The significant increase in Miromatrix Medical's share price is likely to have a positive impact on the company's stock in the short term.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
Motus GI Hldgs shares increased by 35.65% to $0.56.
The significant increase in Motus GI Hldgs' share price is likely to have a positive impact on the company's stock in the short term.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
Reviva Pharmaceuticals stock increased by 43.25% to $5.37.
The significant increase in Reviva Pharmaceuticals' share price is likely to have a positive impact on the company's stock in the short term.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
VYNE Therapeutics shares rose 25.24% to $2.81.
The significant increase in VYNE Therapeutics' share price is likely to have a positive impact on the company's stock in the short term.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
ABVC BioPharma shares decreased by 15.94% to $1.16.
The significant decrease in ABVC BioPharma's share price is likely to have a negative impact on the company's stock in the short term.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
Biotricity stock declined by 15.83% to $1.17.
The significant decrease in Biotricity's share price is likely to have a negative impact on the company's stock in the short term.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
Better Therapeutics stock declined by 16.59% to $0.15.
The significant decrease in Better Therapeutics' share price is likely to have a negative impact on the company's stock in the short term.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
LumiraDx shares declined by 27.2% to $0.09.
The significant decrease in LumiraDx's share price is likely to have a negative impact on the company's stock in the short term.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
Qualigen Therapeutics shares decreased by 22.86% to $0.66.
The significant decrease in Qualigen Therapeutics' share price is likely to have a negative impact on the company's stock in the short term.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
Tenax Therapeutics shares declined by 20.95% to $0.2.
The significant decrease in Tenax Therapeutics' share price is likely to have a negative impact on the company's stock in the short term.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100